ClinicalTrials.govpublic full text
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
cancer of the pharynx, cancer of the larynx, cancer of the neck, paranasal sinus neoplasms, cancer of the head, celecoxib, erlotinib, epidermal growth factor receptor, intensity-modulated radiotherapy, cyclooxygenase-2, reirradiation, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825708
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.